127 related articles for article (PubMed ID: 32727431)
1. Questioning the IGF1 receptor's assigned role in CRC - a case for rehabilitation?
Heckl SM; Pellinghaus M; Behrens HM; Krüger S; Schreiber S; Röcken C
BMC Cancer; 2020 Jul; 20(1):704. PubMed ID: 32727431
[TBL] [Abstract][Full Text] [Related]
2. The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications.
Heckl SM; Wiesener V; Behrens HM; Ulase D; Krüger S; Röcken C
Gastric Cancer; 2019 Nov; 22(6):1130-1142. PubMed ID: 30989432
[TBL] [Abstract][Full Text] [Related]
3. [The expression and significance of IGF1R-Ras/RAGE-HMGB1 pathway in colorectal cancer patients with type 2 diabetes mellitus].
Niu S; Zhao ZG; Lyu XM; Zhao M; Wang XZ; Liu WN; Zhao W; Zhang XH; Wang Y
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):391-395. PubMed ID: 32482028
[No Abstract] [Full Text] [Related]
4. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.
Jin M; Long ZW; Yang J; Lin X
Pathol Oncol Res; 2018 Jan; 24(1):45-57. PubMed ID: 28188432
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous inhibition of IGF1R and EGFR enhances the efficacy of standard treatment for colorectal cancer by the impairment of DNA repair and the induction of cell death.
Oberthür R; Seemann H; Gehrig J; Rave-Fränk M; Bremmer F; Halpape R; Conradi LC; Scharf JG; Burfeind P; Kaulfuß S
Cancer Lett; 2017 Oct; 407():93-105. PubMed ID: 28823963
[TBL] [Abstract][Full Text] [Related]
6. Higher Expression of Proteins in IGF/IR Axes in Colorectal Cancer is Associated with Type 2 Diabetes Mellitus.
Ding J; Li C; Tang J; Yi C; Liu JY; Qiu M
Pathol Oncol Res; 2016 Oct; 22(4):773-9. PubMed ID: 27138191
[TBL] [Abstract][Full Text] [Related]
7. IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.
Li Z; Pan W; Shen Y; Chen Z; Zhang L; Zhang Y; Luo Q; Ying X
Cell Cycle; 2018; 17(10):1212-1219. PubMed ID: 29886785
[TBL] [Abstract][Full Text] [Related]
8. IGF1-mediated HOXA13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R.
Qiao C; Huang W; Chen J; Feng W; Zhang T; Wang Y; Liu D; Ji X; Xie M; Sun M; Fan D; Wu K; Xia L
Cell Death Dis; 2021 Jun; 12(6):564. PubMed ID: 34075028
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathological and prognostic significances of IGF-1R and Livin expression in patients with colorectal cancer.
Zhang Z; Zhang Y; Lao S; Qiu J; Pan Z; Feng X
BMC Cancer; 2022 Aug; 22(1):855. PubMed ID: 35931997
[TBL] [Abstract][Full Text] [Related]
10. The role of insulin-like growth factor 1 and its receptor in the formation and development of colorectal carcinoma.
Zhang R; Xu GL; Li Y; He LJ; Chen LM; Wang GB; Lin SY; Luo GY; Gao XY; Shan HB
J Int Med Res; 2013 Aug; 41(4):1228-35. PubMed ID: 23801064
[TBL] [Abstract][Full Text] [Related]
11. High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancer.
Zaanan A; Calmel C; Henriques J; Svrcek M; Blons H; Desbois-Mouthon C; Merabtene F; Goumard C; Parc Y; Gayet B; Taieb J; Validire P; Louvet C; Fléjou JF; Le Bouc Y; Praz F
Cell Oncol (Dordr); 2020 Apr; 43(2):237-247. PubMed ID: 31823290
[TBL] [Abstract][Full Text] [Related]
12. Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer.
Tran TN; Selinger CI; Yu B; Ng CC; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
J Clin Pathol; 2014 Nov; 67(11):985-91. PubMed ID: 25118293
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
[TBL] [Abstract][Full Text] [Related]
14. Correlations of insulin-like growth factor I and insulin-like growth factor I receptor with the clinicopathological features and prognosis of patients with colon cancer.
Han L; Zhang GF; Cheng YH; Zhao QC
Jpn J Clin Oncol; 2016 Dec; 46(12):1127-1134. PubMed ID: 27737962
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer?
Inno A; Di Salvatore M; Cenci T; Martini M; Orlandi A; Strippoli A; Ferrara AM; Bagalà C; Cassano A; Larocca LM; Barone C
Clin Colorectal Cancer; 2011 Dec; 10(4):325-32. PubMed ID: 21729677
[TBL] [Abstract][Full Text] [Related]
16. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
[TBL] [Abstract][Full Text] [Related]
18. Membranous ABCG2 expression in colorectal cancer independently correlates with shortened patient survival.
Wang X; Xia B; Liang Y; Peng L; Wang Z; Zhuo J; Wang W; Jiang B
Cancer Biomark; 2013; 13(2):81-8. PubMed ID: 23838136
[TBL] [Abstract][Full Text] [Related]
19. High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.
Gately K; Forde L; Cuffe S; Cummins R; Kay EW; Feuerhake F; O'Byrne KJ
Clin Lung Cancer; 2014 Jan; 15(1):58-66. PubMed ID: 24210543
[TBL] [Abstract][Full Text] [Related]
20. Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.
Hartog H; Horlings HM; van der Vegt B; Kreike B; Ajouaou A; van de Vijver MJ; Marike Boezen H; de Bock GH; van der Graaf WT; Wesseling J
Breast Cancer Res Treat; 2011 Oct; 129(3):725-36. PubMed ID: 21107683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]